Literature DB >> 4204397

A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4204397     DOI: 10.1016/0041-3879(73)90013-5

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


× No keyword cloud information.
  9 in total

1.  Plasma and salivary concentrations of isoniazid in man: preliminary findings in two slow acetylator subjects.

Authors:  H G Boxenbaum; I Berkersky; V Mattaliano; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy.

Authors:  Jotam G Pasipanodya; Shashikant Srivastava; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2012-03-30       Impact factor: 9.079

Review 3.  Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors:  W J Burman; K Gallicano; C Peloquin
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 4.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

5.  Intermittent treatment regimens in pulmonary tuberculosis.

Authors:  M Zierski
Journal:  Lung       Date:  1979       Impact factor: 2.584

6.  Assessment of the Efficacy of New Anti-Tuberculosis Drugs.

Authors:  Denis A Mitchison; Geraint R Davies
Journal:  Open Infect Dis J       Date:  2008-12

Review 7.  Clinical pharmacokinetics of isoniazid.

Authors:  W W Weber; D W Hein
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

8.  Role of pharmacogenomics in the treatment of tuberculosis: a review.

Authors:  Geetha Ramachandran; Soumya Swaminathan
Journal:  Pharmgenomics Pers Med       Date:  2012-09-13

Review 9.  What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis.

Authors:  H R Stagg; R J Harris; H-A Hatherell; D Obach; H Zhao; N Tsuchiya; K Kranzer; V Nikolayevskyy; J Kim; M C Lipman; I Abubakar
Journal:  Thorax       Date:  2016-06-13       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.